Table 1 Clinical characteristics of patients with sarcoidosis
From: TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis
Patients with active sarcoidosis (n = 29) | |
 Stage 1 (bilateral hilar lymphadenopathy) | 13 |
 Stage 2 (bilateral hilar lymphadenopathy with pulmonary infiltrates) | 11 |
 Stage 3 (parenchymal infiltrates without hilar adenopathy) | 5 |
 FVC% | 103.33 ± 11.60 |
 FEV1% | 101.16 ± 14.76 |
 DLCO% | 79.33 ± 11.13 |
 TIFF | 92.00 ± 12.94 |
Patients with inactive sarcoidosis (n = 14) | |
 Stage 1 | 11 |
 Stage 2 | 3 |
 Stage 3 | 0 |
 FVC% | 98.20 ± 15.39 |
 FEV1% | 93.10 ± 17.99 |
 DLCO% | 86.77 ± 10.72 |
 TIFF | 80.01 ± 8.99 |